ID   P2RY1_RAT               Reviewed;         373 AA.
AC   P49651;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   29-MAY-2024, entry version 172.
DE   RecName: Full=P2Y purinoceptor 1;
DE            Short=P2Y1;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=Purinergic receptor;
GN   Name=P2ry1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Insulinoma;
RX   PubMed=7779087; DOI=10.1006/bbrc.1995.1798;
RA   Tokuyama Y., Hara M., Jones E.M.C., Fan Z., Bell G.I.;
RT   "Cloning of rat and mouse P2Y purinoceptors.";
RL   Biochem. Biophys. Res. Commun. 211:211-218(1995).
CC   -!- FUNCTION: Receptor for extracellular adenine nucleotides such as ADP
CC       (PubMed:7779087). In platelets, binding to ADP leads to mobilization of
CC       intracellular calcium ions via activation of phospholipase C, a change
CC       in platelet shape, and ultimately platelet aggregation (By similarity).
CC       {ECO:0000250|UniProtKB:P49650, ECO:0000269|PubMed:7779087}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:7779087};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P47900}.
CC   -!- TISSUE SPECIFICITY: Expressed in muscle, heart, liver, kidney, lung,
CC       brain, spleen, but not in testis.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U22830; AAA91303.1; -; mRNA.
DR   RefSeq; NP_036932.1; NM_012800.1.
DR   AlphaFoldDB; P49651; -.
DR   SMR; P49651; -.
DR   BioGRID; 247305; 2.
DR   MINT; P49651; -.
DR   STRING; 10116.ENSRNOP00000019304; -.
DR   BindingDB; P49651; -.
DR   ChEMBL; CHEMBL2497; -.
DR   GuidetoPHARMACOLOGY; 323; -.
DR   GlyCosmos; P49651; 4 sites, No reported glycans.
DR   GlyGen; P49651; 4 sites.
DR   PhosphoSitePlus; P49651; -.
DR   PaxDb; 10116-ENSRNOP00000019304; -.
DR   Ensembl; ENSRNOT00000019305.5; ENSRNOP00000019304.3; ENSRNOG00000014232.5.
DR   Ensembl; ENSRNOT00055031791; ENSRNOP00055025706; ENSRNOG00055018671.
DR   Ensembl; ENSRNOT00060008899; ENSRNOP00060006718; ENSRNOG00060005357.
DR   Ensembl; ENSRNOT00065044985; ENSRNOP00065036870; ENSRNOG00065026099.
DR   GeneID; 25265; -.
DR   KEGG; rno:25265; -.
DR   UCSC; RGD:3242; rat.
DR   AGR; RGD:3242; -.
DR   CTD; 5028; -.
DR   RGD; 3242; P2ry1.
DR   eggNOG; ENOG502QWPV; Eukaryota.
DR   GeneTree; ENSGT01030000234621; -.
DR   HOGENOM; CLU_009579_8_2_1; -.
DR   InParanoid; P49651; -.
DR   OMA; GFCVPFI; -.
DR   OrthoDB; 5347340at2759; -.
DR   PhylomeDB; P49651; -.
DR   TreeFam; TF350009; -.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   Reactome; R-RNO-417957; P2Y receptors.
DR   Reactome; R-RNO-418592; ADP signalling through P2Y purinoceptor 1.
DR   PRO; PR:P49651; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000014232; Expressed in quadriceps femoris and 18 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0044297; C:cell body; IDA:BHF-UCL.
DR   GO; GO:0005929; C:cilium; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:BHF-UCL.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0014069; C:postsynaptic density; IDA:BHF-UCL.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:BHF-UCL.
DR   GO; GO:0048787; C:presynaptic active zone membrane; IDA:SynGO.
DR   GO; GO:0031686; F:A1 adenosine receptor binding; IPI:BHF-UCL.
DR   GO; GO:0043531; F:ADP binding; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0001621; F:G protein-coupled ADP receptor activity; IDA:BHF-UCL.
DR   GO; GO:0045031; F:G protein-coupled ATP receptor activity; IDA:BHF-UCL.
DR   GO; GO:0045028; F:G protein-coupled purinergic nucleotide receptor activity; IDA:BHF-UCL.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:BHF-UCL.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0097746; P:blood vessel diameter maintenance; IMP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; ISO:RGD.
DR   GO; GO:0071415; P:cellular response to purine-containing compound; ISS:UniProtKB.
DR   GO; GO:0042755; P:eating behavior; IMP:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0001973; P:G protein-coupled adenosine receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0035589; P:G protein-coupled purinergic nucleotide receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0008347; P:glial cell migration; IMP:RGD.
DR   GO; GO:0006811; P:monoatomic ion transport; ISO:RGD.
DR   GO; GO:0051100; P:negative regulation of binding; IDA:BHF-UCL.
DR   GO; GO:0010700; P:negative regulation of norepinephrine secretion; IDA:RGD.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030168; P:platelet activation; IEA:InterPro.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:BHF-UCL.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL.
DR   GO; GO:0046887; P:positive regulation of hormone secretion; IDA:RGD.
DR   GO; GO:0032962; P:positive regulation of inositol trisphosphate biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0043270; P:positive regulation of monoatomic ion transport; ISO:RGD.
DR   GO; GO:0060406; P:positive regulation of penile erection; IDA:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0008360; P:regulation of cell shape; ISS:UniProtKB.
DR   GO; GO:0099509; P:regulation of presynaptic cytosolic calcium ion concentration; IDA:SynGO.
DR   GO; GO:0010469; P:regulation of signaling receptor activity; IDA:BHF-UCL.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IDA:SynGO.
DR   GO; GO:0090075; P:relaxation of muscle; IEA:InterPro.
DR   GO; GO:0070848; P:response to growth factor; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IMP:RGD.
DR   GO; GO:0023019; P:signal transduction involved in regulation of gene expression; IDA:BHF-UCL.
DR   CDD; cd15377; 7tmA_P2Y1; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR000142; P2Y1_rcpt.
DR   PANTHER; PTHR24231:SF2; P2Y PURINOCEPTOR 1; 1.
DR   PANTHER; PTHR24231; PURINOCEPTOR-RELATED G-PROTEIN COUPLED RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00595; P2Y1PRNOCPTR.
DR   PRINTS; PR01157; P2YPURNOCPTR.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Cell membrane; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Membrane; Nucleotide-binding; Receptor; Reference proteome;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..373
FT                   /note="P2Y purinoceptor 1"
FT                   /id="PRO_0000070008"
FT   TOPO_DOM        1..51
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        52..74
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P47900"
FT   TOPO_DOM        75..87
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        88..109
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P47900"
FT   TOPO_DOM        110..125
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        126..147
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P47900"
FT   TOPO_DOM        148..166
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        167..188
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P47900"
FT   TOPO_DOM        189..214
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        215..237
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:P47900"
FT   TOPO_DOM        238..260
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        261..284
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:P47900"
FT   TOPO_DOM        285..303
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        304..325
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:P47900"
FT   TOPO_DOM        326..373
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   BINDING         46
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P47900"
FT   BINDING         203..205
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P47900"
FT   BINDING         283..287
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P47900"
FT   BINDING         303..306
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P47900"
FT   BINDING         310
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P47900"
FT   CARBOHYD        11
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        27
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        113
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        197
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        42..296
FT                   /evidence="ECO:0000250|UniProtKB:P47900"
FT   DISULFID        124..202
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
SQ   SEQUENCE   373 AA;  42322 MW;  6DDF676287B5E648 CRC64;
     MTEVPWSAVP NGTDAAFLAG LGSLWGNSTI ASTAAVSSSF RCALIKTGFQ FYYLPAVYIL
     VFIIGFLGNS VAIWMFVFHM KPWSGISVYM FNLALADFLY VLTLPALIFY YFNKTDWIFG
     DVMCKLQRFI FHVNLYGSIL FLTCISAHRY SGVVYPLKSL GRLKKKNAIY VSVLVWLIVV
     VAISPILFYS GTGIRKNKTV TCYDSTSDEY LRSYFIYSMC TTVAMFCIPL VLILGCYGLI
     VRALIYKDLD NSPLRRKSIY LVIIVLTVFA VSYIPFHVMK TMNLRARLDF QTPEMCDFND
     RVYATYQVTR GLASLNSCVD PILYFLAGDT FRRRLSRATR KASRRSEANL QSKSEEMTLN
     ILSEFKQNGD TSL
//
